NuGen Medical Devices Inc.
NGMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 204.7% | 117.5% | 10.7% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 51.7% | 49.7% | -363.1% | 67% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -287.6% | -2,233.3% | -2,767.8% | -3,752.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -517.5% | -2,825% | -3,661.1% | -5,163.2% |
| EPS Diluted | -0.024 | -0.056 | -0.062 | -0.1 |
| % Growth | 56.3% | 9.9% | 38.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |